Digestive System Carcinoma — Trials

Digestive System Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

7,545 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,124
Recruiting: 1,216
Ph III recruiting: 129
Growth YoY: +12.6%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (885)

clinicaltrialsPublishedShowing 151–200 of 544 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05621499	HAIC or Lenvatinib Combined With Sintilimab for High Recurrence Risk Resectable Solitary Hepatocellular Carcinoma	active not recruiting	N/A	60	Tianjin Medical University Cancer Institute and HospitalOTHER	1	Jul 29, 2026	clinicaltrials
NCT06506955	Futibatinib in Patients Previously Enrolled in an Antecedent Futibatinib as Monotherapy or Combination Therapy.	active not recruiting	Phase 2 / Phase 3	15	Taiho Oncology, Inc.INDUSTRY	5	Jul 28, 2026